It has been suggested that both innate and adaptive immune activation can further trigger and magnify liver inflammation during the occurrence and progression of NAFLD/NASH [41, 42], referring to the activation of resident Kupffer cells and recruitment of white blood cells such as neutrophils, dendritic cells, and CD8+ T cells [43–46]. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.